| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |